<unk>  is a common entity that presents as a spectrum of symptoms ranging from complete absence of symptoms to myalgia, myositis and rhabdomyolysis.<unk> , which is a general term that describes any pathology of the muscle, occurs in around 10 to 15% of patients taking<unk> s. The pathophysiology of<unk>  is complex. As for the treatment, it is guided by the severity of the symptoms and the degree of increase in creatine kinase levels.
N-of-1 trials have examined this:<unk> WISE
TaSINI
Wood
Statin induced myopathy
Infectious myositis
Scleromyositis
Eosinophilia myalgia syndrome
Polymyalgia rheumatica
Pyomyositis
Thyrotoxic myopathy
Gelsolin related amyloidosis